Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Analysis Group, Inc., Boston

1 abstract

Abstract
A PREDICTION MODEL THAT IDENTIFIES PATIENTS MOST LIKELY TO BENEFIT FROM FIRST-LINE THERAPY WITH ADALIMUMAB PLUS METHOTREXATE IN EARLY RHEUMATOID ARTHRITIS
Org: The Karolinska Institute, Stockholm, Sweden, Analysis Group, Inc., Boston, AbbVie Inc., North Chicago, IL, Former employee of AbbVie Inc., North Chicago, United States,